Omeros (OMER)
Commercializes YARTEMLEA for TA-TMA while advancing complement and specialty therapeutics.
$21.13
vs last close+2.64 (+14.28%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 51 days
EPS estimate
−$0.05
Revenue estimate
$36.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.54−$0.58−$0.43−$0.47$3.14−$0.24$0.15Pending
Estimate−$0.78−$0.57−$0.55−$0.58−$0.55−$0.40−$0.27−$0.05
Surprise+30.4%−2.5%+21.8%+19.0%+670.9%+40.0%+155.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$412.0K————$9.9M$28.5MPending
Estimate—$400.0K$312.5K$312.5K$1.6M$4.2M$12.7M$36.7M
Surprise—————+136.4%+124.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.91 | — | — |
| Sep 2028 | $1.88 | — | — |
| Jun 2028 | $1.93 | — | — |
| Mar 2028 | $1.98 | — | — |
| Dec 2027 | $1.05 | — | — |
| Sep 2027 | $1.07 | — | — |
| Jun 2027 | $1.12 | — | — |
| Mar 2027 | $1.04 | — | — |
| Dec 2026 | $0.05 | — | — |
| Nov 2026 | −$0.05 | — | — |
| Aug 2026 | −$0.27 | $0.15 | +155.9% |
| May 2026 | −$0.40 | −$0.24 | +40.0% |
| Mar 2026 | −$0.55 | $3.14 | +670.9% |
| Nov 2025 | −$0.58 | −$0.47 | +19.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.91 | — | — | $264.1M | — | — | — |
| Sep 2028 | $1.88 | — | — | $253.9M | — | — | — |
| Jun 2028 | $1.93 | — | — | $253.9M | — | — | — |
| Mar 2028 | $1.98 | — | — | $267.6M | — | — | — |
| Dec 2027 | $1.05 | — | — | $164.7M | — | — | — |
| Sep 2027 | $1.07 | — | — | $158.4M | — | — | — |
| Jun 2027 | $1.12 | — | — | $158.4M | — | — | — |
| Mar 2027 | $1.04 | — | — | $152.0M | — | — | — |
| Dec 2026 | $0.05 | — | — | $50.5M | — | — | — |
| Nov 12, 2026 | −$0.05 | — | — | $36.7M | — | — | — |
| Aug 13, 2026 | −$0.27 | $0.15 | +155.9% | $12.7M | $28.5M | +124.8% | +26.6% |
| May 13, 2026 | −$0.40 | −$0.24 | +40.0% | $4.2M | $9.9M | +136.4% | −7.7% |
| Mar 31, 2026 | −$0.55 | $3.14 | +670.9% | $1.6M | — | — | +14.4% |
| Nov 13, 2025 | −$0.58 | −$0.47 | +19.0% | $312.5K | — | — | +25.3% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 13, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 1, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 7, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |